[Analysis of clinical factors of bendamustine combined with rituximab in the treatment of recurrent follicular lymphoma].
Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):513-517. doi: 10.3760/cma.j.issn.0253-2727.2022.06.012.
Zhonghua Xue Ye Xue Za Zhi. 2022.
PMID: 35968596
Chinese.
No abstract available.